Canadian research breakthrough holds promise for development of effective cancer therapies

Researchers Dr Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Universite de Montreal, and Dr Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies...

Read the whole article on

More from